Management of Severe Exacerbations of COPD or Asthma
COPD Exacerbations: Severity-Based Approach
- For severe exacerbations of COPD, combination therapy with salbutamol and ipratropium is superior to salbutamol alone, according to the British Thoracic Society guidelines 1, 2
- The American College of Chest Physicians confirms that combination therapy reduces the risk of acute exacerbations compared to albuterol alone (Grade 2B recommendation) 3
- Combination therapy provides superior bronchodilation by targeting different receptors in the airways 3
- Clinical benefits include improvements in quality of life, exercise tolerance, and lung function compared with monotherapy 3
- For moderate exacerbations, either salbutamol or ipratropium bromide alone is appropriate as initial therapy, with nebulized bronchodilators given on arrival and at 4-6 hourly intervals thereafter 1, 2
Acute Severe Asthma: Clear Benefit of Combination
- The American College of Allergy, Asthma, and Immunology confirms that ipratropium provides additive benefit in moderate or severe exacerbations, reducing hospitalizations especially in patients with severe airflow obstruction 5
- For adults with severe asthma, treatment includes oxygen plus oral steroids plus nebulised salbutamol 5 mg, repeated 4-6 hourly if improving, with ipratropium bromide 500 µg added if not improving 4
- For children with severe asthma, nebulised salbutamol 5 mg (or 0.15 mg/kg) is repeated 1-4 hourly if improving, with ipratropium bromide 250 µg added if not improving 4
Critical Administration Details for COPD Patients
- In patients with CO2 retention and acidosis, nebulizers must be driven by compressed air, NOT oxygen, according to the British Thoracic Society guidelines 1, 2, 3
- Oxygen can be continued via nasal prongs at 1-2 L/min during nebulization to prevent desaturation 1, 2
- Do not give FiO2 >28% via Venturi mask or >2 L/min via nasal cannulae until arterial blood gases are known in patients with COPD history aged ≥50 years 1
Monitoring Requirements
- Check blood gases within 60 minutes of starting oxygen and within 60 minutes of any change in inspired oxygen concentration 1
- pH below 7.26 is predictive of poor outcome 1
Common Pitfalls to Avoid
- Do not use combination therapy as first-line for moderate exacerbations - start with monotherapy and escalate if needed, according to the British Thoracic Society guidelines 1, 2
- Do not power nebulizers with oxygen in hypercapnic COPD patients - use compressed air 1, 2, 3
- Do not rely on nebulizer "dryness" as endpoint - continue until about one minute after "spluttering" occurs (5-10 minutes) 4
- In patients with glaucoma, use mouthpiece rather than mask when administering ipratropium to avoid eye exposure 4, 6